• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SVP, Chief Accounting Officer Stewart Deborah sold $85,970 worth of shares (15,457 units at $5.56), decreasing direct ownership by 5% to 285,396 units (SEC Form 4)

    6/11/25 7:00:04 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Stewart Deborah

    (Last) (First) (Middle)
    C/O AVEANNA HEALTHCARE HOLDINGS INC.
    400 INTERSTATE NORTH PARKWAY SE

    (Street)
    ATLANTA GA 30339

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Aveanna Healthcare Holdings, Inc. [ AVAH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    SVP, Chief Accounting Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    06/10/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 per share 06/10/2025 S 15,457 D $5.5619(1) 285,396 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This transaction was executed in multiple trades during the day at prices ranging from $5.55 to $5.60. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
    /s/ Jonathan Beckler, Attorney-in-Fact 06/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AVAH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    8/19/2025$9.50Equal Weight → Overweight
    Barclays
    8/19/2025$8.00Sell → Neutral
    UBS
    7/21/2025$6.00Hold → Buy
    Jefferies
    7/2/2025$5.50Equal Weight
    Barclays
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    More analyst ratings

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aveanna upgraded by Barclays with a new price target

    Barclays upgraded Aveanna from Equal Weight to Overweight and set a new price target of $9.50

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by UBS with a new price target

    UBS upgraded Aveanna from Sell to Neutral and set a new price target of $8.00

    8/19/25 8:29:17 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by Jefferies with a new price target

    Jefferies upgraded Aveanna from Hold to Buy and set a new price target of $6.00

    7/21/25 8:21:50 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Aveanna Healthcare Holdings Inc.

    SCHEDULE 13G/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    8/11/25 3:19:31 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form 10-Q/A filed by Aveanna Healthcare Holdings Inc.

    10-Q/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    8/8/25 8:00:32 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    8/8/25 9:00:38 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Administrative Officer Reisz Edwin C. was granted 139,665 shares and covered exercise/tax liability with 49,783 shares, increasing direct ownership by 7% to 1,371,497 units (SEC Form 4)

    4/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/16/25 7:00:04 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner J.H. Whitney Equity Partners Vii, Llc disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:17:51 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner Vigano Paul R disposed of 81,882 shares (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    7/11/25 9:14:06 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aveanna to Participate at the Deutsche Bank Healthcare Summit

    ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Deutsche Bank Healthcare Summit in New York on September 10, 2025. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of e

    8/19/25 7:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 7, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754011. The replay will be available until August 14, 20

    7/17/25 6:30:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    Aveanna Healthcare Holdings Announces Appointment of New Director

    ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

    11/4/24 7:30:02 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

    ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

    4/3/24 6:30:06 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

    ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

    12/11/23 7:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Financials

    Live finance-specific insights

    View All

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 7, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754011. The replay will be available until August 14, 20

    7/17/25 6:30:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

    First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

    5/8/25 6:30:59 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/24 4:00:42 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/22 6:43:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care